Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-081361

Options or other derivatives

  • Chief Medical Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Naimish Chief Medical Officer 2025-05-30 Grant or award · Restricted Stock Units +25,000 25,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…